Key Dates
- May 28, 2021 - NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed). See NOFO PAR-21-220.
National Institute on Aging (NIA)
The National Institute on Aging (NIA) intends to reissue PAR-21-220 - NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed). PAR-21-220 is an expired Notice of Funding Opportunity (NOFO) that solicited applications for Pathway to Independence Awards in the area of translational research related to Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD). The reissued NOFO will revise the initiative.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This Notice encourages postdoctoral researchers with expertise and insights into the area of translational research in AD/ADRD to consider applying to the reissued NOFO.
Consistent with PAR-21-220, it is anticipated that the reissue will use the Career Transition Award/Research Transition Award (K99/R00) activity code.
The NOFO is expected to be published in Winter 2024, and the first application due date is expected to be in February 2025. The NOFO will not accept applications for standard due dates in October 2024 and November 2024. Candidates considering a K99/R00 application in Fall 2024 that aligns with NIA's mission are encouraged to consider applying to a K99/R00 parent announcement. Parent announcements are broad funding opportunities allowing applicants to submit investigator-initiated applications for specific activity codes. A list of current K99/R00 parent announcements can be found here.
Additional details regarding the planned NOFO are provided below.
The purpose of the NOFO is to enhance the translational research workforce for AD/ADRD, including frontotemporal dementia, Lewy body dementia, and vascular dementia. The pathway to independence award will support early career investigators from various backgrounds, including those from groups underrepresented in the biomedical sciences, to gain critical translational research skills that they can apply to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). The program will support highly trained translational researchers as they transition to research independence in the field of AD/ADRD. The long-term goal of the program is to expand the pool of translational researchers who can effectively participate in and/or lead a team-science, interdisciplinary approach to studies of AD/ADRD treatment, prevention, early detection, and disease management and care.
The program is designed to facilitate the transition of talented postdoctoral researchers who have up to 4 years of postgraduation research experience to independent tenure-track (or equivalent) faculty positions.
Funding Information
TBD
In the K99 phase, NIH will contribute up to $75,000 in direct costs for salary. In addition, NIH will cover fringe benefits and contribute up to $25,000 for research and career development costs. In the R00 phase, the total cost may not exceed $249,000 per year.
93.866
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Jamie Lahvic, Ph.D.
National Institute on Aging (NIA)
Email: [email protected]
and Human Services (HHS)
